Skip to main content
. Author manuscript; available in PMC: 2011 Jun 24.
Published in final edited form as: Neuron. 2010 Jun 24;66(6):848–858. doi: 10.1016/j.neuron.2010.05.007

Figure 2. Nova2 controls laminar formation of late generated neurons.

Figure 2

(A,C) BrdU-labeling was performed at E14.0 or E16.0 and cortical sections of WT or Nova2 KO animals were immunostained with BrdU antibody at P0 as indicated. (B,D) Graphs show a quantification of BrdU positive cells percentage in each of 10 bins (along the dorsal/ventral axis) relative to the total number of BrdU positive cells in WT or Nova2 KO. Data represents mean +/– standard deviation (SD) from experiments using three independent animals for each genotype. Results showed statistically significant differences for Nova2 KO relative to WT in both E14 and E16 BrdU injections (F(9,35) = 6.56, P<0.0001, F(9.35) = 2.9348, p=0.0106, respectively by repeated measures ANOVA). Scale bar; 100 μm.